sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Asia Pacific Wearable Injectors Market Scope And Analysis

  • Report Code : TIPRE00013299
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 117
Buy Now

Asia Pacific Wearable Injectors Market Scope and Key Players Analysis by 2027

Buy Now

Asia Pacific Wearable Injectors Market Report Asia Pacific Wearable Injectors Market Size and Share Asia Pacific Wearable Injectors Market Scope and Analysis

Asia Pacific Wearable Injectors Market Report Scope

Report Attribute Details
Market size in 2019 US$ 1160.40 Million
Market Size by 2027 US$ 2939.97 Million
Global CAGR (2020 - 2027) 12.4%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Type
  • On-Body Injectors
  • Off-Body Injectors
By Application
  • Diabetes
  • Oncology
  • Cardiovascular Disease
  • Autoimmune Disease
  • Other Applications
By End User
  • Hospitals and Clinics
  • Homecare Setting
  • Other End User
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • BD
  • CeQur SA
  • Debiotech S A
  • E3D Elcam Drug Delivery Devices
  • Gerresheimer AG
  • Tandem Diabetes Care Inc
  • West Pharmaceutical Services Inc
  • Ypsomed AG
  • Medtronic